# Ketamine-assisted Therapy for Advanced GI Cancer

> **NCT06077487** · PHASE4 · TERMINATED · sponsor: **Brian Anderson, MD** · enrollment: 1 (actual)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma
- Pain, Acute
- Gastrointestinal Cancers
- Demoralization

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Ketamine Injectable Product
- **BEHAVIORAL:** Meaning and Purpose therapy
- **OTHER:** Placebo
- **OTHER:** Questionnaires

## Key facts

- **NCT ID:** NCT06077487
- **Lead sponsor:** Brian Anderson, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-05-17
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Slow Accrual
- **Last updated:** 2025-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06077487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06077487, "Ketamine-assisted Therapy for Advanced GI Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06077487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*